Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 8.115 Q1 | 391 | 317 | 492 | 7006 | 3213 | 170 | 6.53 | 22.10 |  |
| 2 | Trends in Pharmacological Sciences | journal | 3.825 Q1 | 244 | 117 | 489 | 5609 | 3267 | 392 | 7.46 | 47.94 | |
| 3 | Human Genomics | journal | 2.980 Q1 | 68 | 36 | 7 | 587 | 11 | 7 | 1.57 | 16.31 | |
| 4 | Natural Product Reports | journal | 2.451 Q1 | 211 | 46 | 120 | 7652 | 855 | 118 | 7.01 | 166.35 | |
| 5 | Neuropsychopharmacology | journal | 2.241 Q1 | 249 | 250 | 659 | 13878 | 3291 | 620 | 4.75 | 55.51 | |
| 6 | Neuropharmacology | journal | 1.901 Q1 | 191 | 261 | 696 | 13239 | 2861 | 696 | 4.03 | 50.72 | |
| 7 | Environmental Pollution | journal | 1.672 Q1 | 301 | 282 | 830 | 10872 | 2253 | 826 | 2.46 | 38.55 | |
| 8 | Antiviral Therapy | journal | 1.624 Q1 | 93 | 118 | 164 | 4626 | 633 | 157 | 3.67 | 39.20 | |
| 9 | Clinical Pharmacokinetics | journal | 1.578 Q1 | 184 | 73 | 250 | 6098 | 1586 | 246 | 6.53 | 83.53 | |
| 10 | Tetrahedron | journal | 1.466 Q1 | 236 | 1211 | 3300 | 52315 | 9848 | 3286 | 2.83 | 43.20 | |
| 11 | Journal of Antimicrobial Chemotherapy | journal | 1.435 Q1 | 221 | 465 | 1265 | 11630 | 4622 | 1023 | 3.72 | 25.01 | |
| 12 | Receptors and Channels | journal | 1.369 Q1 | 44 | 19 | 92 | 868 | 279 | 85 | 3.28 | 45.68 | |
| 13 | International Journal of Neuropsychopharmacology | journal | 1.338 Q1 | 125 | 70 | 155 | 2716 | 476 | 138 | 2.95 | 38.80 | |
| 14 | Toxicological Sciences | journal | 1.314 Q1 | 207 | 297 | 777 | 11408 | 2535 | 744 | 3.32 | 38.41 | |
| 15 | Tetrahedron Letters | journal | 1.300 Q1 | 181 | 2123 | 6648 | 56322 | 17545 | 6647 | 2.70 | 26.53 | |
| 16 | Pharmacogenomics Journal | journal | 1.284 Q1 | 95 | 58 | 174 | 2214 | 586 | 150 | 3.35 | 38.17 | |
| 17 | Drug Safety | journal | 1.211 Q1 | 140 | 94 | 264 | 6299 | 1152 | 253 | 4.12 | 67.01 | |
| 18 | Current Opinion in Drug Discovery and Development | journal | 1.182 Q1 | 85 | 78 | 269 | 4338 | 911 | 252 | 3.77 | 55.62 | |
| 19 | American Journal of PharmacoGenomics | journal | 1.175 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 20 | Current Opinion in Molecular Therapeutics | journal | 1.175 Q1 | 67 | 87 | 263 | 4579 | 816 | 240 | 3.20 | 52.63 | |
| 21 | Addictive Behaviors | journal | 1.165 Q1 | 149 | 191 | 289 | 4594 | 650 | 288 | 2.09 | 24.05 | |
| 22 | Expert Opinion on Investigational Drugs | journal | 1.078 Q1 | 117 | 136 | 644 | 11132 | 2222 | 621 | 4.21 | 81.85 | |
| 23 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.072 Q1 | 106 | 74 | 143 | 2269 | 323 | 143 | 1.81 | 30.66 | |
| 24 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.068 Q1 | 99 | 18 | 32 | 2144 | 94 | 31 | 3.09 | 119.11 | |
| 25 | Food Additives and Contaminants | journal | 1.026 Q1 | 121 | 127 | 432 | 3757 | 859 | 424 | 1.80 | 29.58 | |
| 26 | Critical Reviews in Toxicology | journal | 1.004 Q1 | 129 | 13 | 72 | 2428 | 229 | 71 | 3.89 | 186.77 | |
| 27 | Toxicon | journal | 0.966 Q1 | 144 | 219 | 670 | 8189 | 1518 | 662 | 1.91 | 37.39 | |
| 28 | Pharmacogenomics | journal | 0.933 Q1 | 100 | 98 | 219 | 4704 | 572 | 188 | 2.56 | 48.00 | |
| 29 | Expert Opinion on Therapeutic Targets | journal | 0.930 Q1 | 106 | 54 | 162 | 4953 | 365 | 155 | 2.60 | 91.72 | |
| 30 | Expert Opinion on Biological Therapy | journal | 0.928 Q1 | 102 | 170 | 292 | 13679 | 799 | 280 | 2.59 | 80.46 | |
| 31 | Bioorganic and Medicinal Chemistry Letters | journal | 0.927 Q1 | 166 | 1178 | 2458 | 26805 | 6202 | 2454 | 2.55 | 22.75 | |
| 32 | Journal of Psychopharmacology | journal | 0.923 Q1 | 135 | 81 | 188 | 3428 | 463 | 173 | 2.17 | 42.32 | |
| 33 | PharmacoEconomics | journal | 0.907 Q1 | 118 | 121 | 318 | 5062 | 947 | 307 | 2.65 | 41.83 | |
| 34 | British Journal of Clinical Pharmacology | journal | 0.904 Q2 | 167 | 219 | 590 | 5397 | 1657 | 516 | 2.57 | 24.64 | |
| 35 | BMC Clinical Pharmacology | journal | 0.897 Q2 | 43 | 6 | 16 | 212 | 33 | 16 | 1.33 | 35.33 | |
| 36 | Food and Chemical Toxicology | journal | 0.877 Q1 | 203 | 209 | 505 | 8623 | 1303 | 491 | 2.63 | 41.26 | |
| 37 | Drug Discovery Today | journal | 0.851 Q2 | 215 | 380 | 1073 | 8164 | 2199 | 833 | 2.23 | 21.48 | |
| 38 | Bioorganic and Medicinal Chemistry | journal | 0.811 Q1 | 187 | 610 | 1330 | 20849 | 3021 | 1328 | 2.21 | 34.18 | |
| 39 | Alcohol and Alcoholism | journal | 0.789 Q2 | 109 | 95 | 288 | 3004 | 650 | 271 | 1.96 | 31.62 | |
| 40 | Current Opinion in Investigational Drugs | journal | 0.780 Q2 | 83 | 158 | 449 | 7594 | 1156 | 418 | 2.66 | 48.06 | |
| 41 | Clinical and Experimental Pharmacology and Physiology | journal | 0.773 Q2 | 115 | 180 | 550 | 5535 | 1054 | 545 | 1.80 | 30.75 | |
| 42 | Journal of Antibiotics | journal | 0.773 Q2 | 92 | 112 | 440 | 1752 | 647 | 368 | 1.45 | 15.64 | |
| 43 | Journal of Microencapsulation | journal | 0.772 Q1 | 88 | 70 | 201 | 1483 | 373 | 200 | 1.81 | 21.19 | |
| 44 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.741 Q1 | 69 | 117 | 153 | 4033 | 437 | 152 | 2.91 | 34.47 | |
| 45 | BioDrugs | journal | 0.737 Q2 | 79 | 35 | 172 | 3364 | 468 | 167 | 2.25 | 96.11 | |
| 46 | Journal of Drug Targeting | journal | 0.707 Q1 | 107 | 70 | 177 | 2539 | 387 | 170 | 2.01 | 36.27 | |
| 47 | British Journal of Clinical Pharmacology, Supplement | journal | 0.705 Q1 | 33 | 7 | 38 | 244 | 131 | 35 | 3.65 | 34.86 | |
| 48 | Xenobiotica | journal | 0.703 Q2 | 89 | 73 | 242 | 2773 | 518 | 240 | 1.90 | 37.99 | |
| 49 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.697 Q2 | 57 | 44 | 129 | 1924 | 230 | 115 | 1.72 | 43.73 | |
| 50 | Chemical Biology and Drug Design | journal | 0.685 | 91 | 79 | 250 | 2611 | 422 | 246 | 1.73 | 33.05 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data